AP55541CP-N EIG121 (C-term) Control Peptide

Search for all "EIG121"

50 µg / €160.00
Please visit the country specific website of Acris Antibodies or contact your local Distributor to buy this product.

Quick Overview

anti EIG121

Product Description for EIG121

anti EIG121.
Properties: (C-term) Control Peptide

Properties for EIG121

Product Category Control Peptides
Quantity 50 µg
Shipping to Worldwide
PDF datasheet View Datasheet
Manufacturer Acris Antibodies GmbH
Material safety datasheet MSDS for Polyclonal Antibodies (de)

Datasheet Extract

Immunogen
GeneID:
1957
Property C-term
Application

The peptide is used for blocking the activity of EIG121 antibody Cat.-No. AP55541PU-N. It usually blocks the antibody activity completely in Western blot by incubating the peptide with equal volume of antibody for 30 min at 37°C.

Concentration 0.2 mg/ml
General Readings Deng L, Broaddus RR, McCampbell A, et al. Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer. Clin. Cancer Res. 2005; 11:8258-64.
Storage

Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
Avoid repeated freezing and thawing.
Shelf life: one year from despatch.

Format
Buffer System:
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% BSA and 0.02% Sodium azide
State:
Liquid peptide
Specificity
Specificity:
Control peptide for AP55541PU-N.Peptide containing 18 amino acids near the carboxy terminus of human EIG121.
Species:
Human

Accessory Products

  • LinkedIn